Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02127398
PHASE2

Stool Transplants to Treat Refractory Clostridium Difficile Colitis

Sponsor: Duke University

View on ClinicalTrials.gov

Summary

It has been shown that restoration of the normal makeup of the bowel bacterial population is the most effective way to treat recurrent colitis due to Clostridium difficile. Restoration of the normal bowel bacterial population is best done by transplanting stool from a healthy donor. The investigators wish to transplant stool from healthy donors to treat recurrent C. difficile colitis by incorporating the stool into capsules that are administered by the oral route.

Official title: Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

77

Start Date

2016-04

Completion Date

2026-05

Last Updated

2025-08-13

Healthy Volunteers

No

Interventions

BIOLOGICAL

fecal microbiota

fecal microbiota in capsule form

Locations (1)

Duke University Medical Center

Durham, North Carolina, United States